Department of Medical Microbiology, University of Ghana Medical School, Accra P.O. Box GP 4236, Ghana.
FleRhoLife Research Consult, Accra P.O. Box TS 853, Ghana.
Int J Environ Res Public Health. 2022 Sep 1;19(17):10927. doi: 10.3390/ijerph191710927.
Nasopharyngeal carriage of aerobic Gram-negative bacilli (GNB) may precede the development of invasive respiratory infections. We assessed the prevalence of nasopharyngeal carriage of aerobic GNB and their antimicrobial resistance patterns among healthy under-five children attending seven selected day-care centres in the Accra metropolis of the Greater Accra region of Ghana from September to December 2016. This cross-sectional study analysed a total of 410 frozen nasopharyngeal samples for GNB and antimicrobial drug resistance. The GNB prevalence was 13.9% (95% CI: 10.8-17.6%). The most common GNB were (26.3%), (24.6%), and (17.5%). Resistance was most frequent for cefuroxime (73.7%), ampicillin (64.9%), and amoxicillin/clavulanic acid (59.6%). The organisms were least resistant to gentamicin (7.0%), amikacin (8.8%), and meropenem (8.8%). Multidrug resistance (MDR, being resistant to ≥3 classes of antibiotics) was observed in 66.7% (95% CI: 53.3-77.8%). Extended-spectrum beta-lactamase (ESBL)-producing bacteria constituted 17.5% (95% CI: 9.5-29.9%), AmpC-producing bacteria constituted 42.1% (95% CI: 29.8-55.5%), and carbapenemase-producing bacteria constituted 10.5% (95% CI: 4.7-21.8%) of isolates. The high levels of MDR are of great concern. These findings are useful in informing the choice of antibiotics in empiric treatment of GNB infections and call for improved infection control in day-care centres to prevent further transmission.
鼻咽部携带需氧革兰氏阴性杆菌(GNB)可能先于侵袭性呼吸道感染的发生。我们评估了加纳大阿克拉地区阿克拉都会区的 7 家选定日托中心的健康 5 岁以下儿童鼻咽部携带需氧 GNB 及其抗生素耐药模式的流行情况。这项横断面研究共分析了 410 份冷冻鼻咽部 GNB 样本和抗生素耐药性。GNB 的患病率为 13.9%(95%CI:10.8-17.6%)。最常见的 GNB 是 (26.3%)、 (24.6%)和 (17.5%)。头孢呋辛(73.7%)、氨苄西林(64.9%)和阿莫西林/克拉维酸(59.6%)的耐药率最高。这些细菌对庆大霉素(7.0%)、阿米卡星(8.8%)和美罗培南(8.8%)的耐药性最低。耐多药(对≥3 类抗生素耐药)的发生率为 66.7%(95%CI:53.3-77.8%)。产超广谱β-内酰胺酶(ESBL)的细菌占 17.5%(95%CI:9.5-29.9%),产 AmpC 的细菌占 42.1%(95%CI:29.8-55.5%),产碳青霉烯酶的细菌占 10.5%(95%CI:4.7-21.8%)。高度耐多药令人高度关注。这些发现有助于指导 GNB 感染经验性治疗中抗生素的选择,并呼吁在日托中心加强感染控制,以防止进一步传播。